• 1. An approach to 7-aza-1-phosphanorbornane complexes: strain promoted rearrangement of 1-iminylphosphirane complexes and cycloaddition with olefins?
  Yang Xu,Min Wang,Donghui Wei,Rongqiang Tian,Zheng Duan,Fran?ois Mathey Dalton Trans., 2019,48, 5523-5526
• 2. An artificial enzyme cascade amplification strategy for highly sensitive and specific detection of breast cancer-derived exosomes?
  Huiying Xu,Lu Zheng,Yu Zhou,Bang-Ce Ye Analyst, 2021,146, 5542-5549
• 3. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453
• 4. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 5. An inter-tangled network of redox-active and conducting polymers as a cathode for ultrafast rechargeable batteries
  Jieun Kim,Han-Saem Park,Tae-Hee Kim,Sung Yeol Kim,Hyun-Kon Song Phys. Chem. Chem. Phys., 2014,16, 5295-5300

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates Nitro fatty acids

Recent Advances in the Study of [1-(nitromethyl)cyclobutyl]acetic Acid (CAS: 779310-32-6)

The compound [1-(nitromethyl)cyclobutyl]acetic Acid (CAS: 779310-32-6) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This research brief aims to provide an overview of the latest findings related to this compound, focusing on its synthesis, biological activity, and potential applications in drug development.

Recent studies have highlighted the synthetic versatility of [1-(nitromethyl)cyclobutyl]acetic Acid, which serves as a key intermediate in the preparation of various bioactive molecules. Its cyclobutyl ring and nitromethyl group offer distinct reactivity patterns that can be exploited for the development of novel pharmacophores. Researchers have successfully utilized this compound in the synthesis of small-molecule inhibitors targeting enzymes involved in inflammatory pathways, showcasing its potential in anti-inflammatory drug discovery.

In terms of biological activity, preliminary in vitro studies have demonstrated that derivatives of [1-(nitromethyl)cyclobutyl]acetic Acid exhibit promising inhibitory effects on specific protein targets associated with metabolic disorders. One study reported a significant reduction in enzyme activity when tested against a panel of metabolic enzymes, suggesting its potential utility in the treatment of conditions such as diabetes and obesity. Further investigations are underway to elucidate the precise mechanism of action and optimize the compound's pharmacokinetic properties.

The structural features of [1-(nitromethyl)cyclobutyl]acetic Acid also make it a valuable candidate for medicinal chemistry applications. Its compact cyclobutyl ring provides rigidity, while the acetic acid moiety offers opportunities for further functionalization. Recent computational studies have employed molecular docking simulations to predict the binding affinity of this compound with various biological targets, yielding encouraging results that warrant experimental validation.

Despite these advancements, challenges remain in the development of [1-(nitromethyl)cyclobutyl]acetic Acid-based therapeutics. Issues such as metabolic stability, bioavailability, and selectivity need to be addressed through systematic structure-activity relationship (SAR) studies. Current research efforts are focused on designing analogs with improved pharmacological profiles while maintaining the core structural advantages of the parent compound.

In conclusion, [1-(nitromethyl)cyclobutyl]acetic Acid (CAS: 779310-32-6) represents a promising scaffold for drug discovery with multiple potential applications. Ongoing research continues to uncover new insights into its biological activities and synthetic utility, positioning it as a compound of significant interest in the pharmaceutical industry. Future studies should prioritize the translation of these findings into clinically relevant therapeutics, potentially addressing unmet medical needs in various disease areas.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)